SuperworthKALA BIO shares outstanding KALA
Diluted shares outstanding, averaged over each quarter, from 2016.
- Latest quarter, to Jun 30, 2026
- 74.2K
- On a year earlier
- −43.1%
- fewer shares
KALA BIO had 74.2K diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 43.1% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 252.7K | +169% |
| FY2024 | 93.9K | +73% |
| FY2023 | 54.2K | +68% |
| FY2022 | 32.2K | +15% |
| FY2021 | 28K | −38% |
| FY2020 | 45.5K | +63% |
| FY2019 | 27.9K | +5% |
| FY2018 | 26.6K | +373% |
| FY2017 | 5.6K | +495% |
| FY2016 | 945 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 74.2K | −43% | |
| Q1 FY26 | 11.9M | +9255% | |
| Q4 FY25 | 252.7K | +169% | |
| Q3 FY25 | 140.8K | +52% | |
| Q2 FY25 | 130.3K | +115% | |
| Q1 FY25 | 126.9K | +126% | |
| Q4 FY24 | 93.9K | +73% | |
| Q3 FY24 | 92.6K | +81% | |
| Q2 FY24 | 60.6K | +27% | |
| Q1 FY24 | 56.3K | +36% | |
| Q4 FY23 | 54.2K | +68% | |
| Q3 FY23 | 51K | +69% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on KALA BIO
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.